Home / News and media / Stock exchange releases / Archive / 2012

2012

May 1st 2012 4:00 PM Stock Exchange Release

U.S. District Court gives decision on Precedex® patent litigation
Apr 26th 2012 7:25 PM Stock Exchange Release

Orion sues Mylan in the U.S. to enforce its U.S. patents covering the proprietary drug Stalevo®
Apr 24th 2012 12:00 PM Stock Exchange Release

Orion Group Interim Report January-March 2012
Apr 10th 2012 9:45 AM Stock Exchange Release

Orion invites analysts and media to Q1 news conference on Tuesday 24 April 2012
Apr 10th 2012 9:00 AM Stock Exchange Release

Orion Corporation: 300,000 Orion A-shares converted into B-shares
Mar 26th 2012 9:00 AM Stock Exchange Release

Orion comments on ANDA filed by Mylan Pharmaceuticals Inc. for a generic version of Orion's proprietary drug Stalevo® in the United States
Mar 20th 2012 5:00 PM Stock Exchange Release

Orion Oyj : Orion Corporation: Organising meeting of the Board of Directors
Mar 20th 2012 4:30 PM Stock Exchange Release

Orion Oyj : Decisions by the AGM on 20 March 2012
Mar 12th 2012 6:45 PM Stock Exchange Release

Orion Corporation: Transfer of 87,763 own B-shares on 12 March 2012
Mar 6th 2012 11:35 AM Stock Exchange Release

Orion Group Annual Report 2011 published
Feb 7th 2012 12:15 PM Stock Exchange Release

Notice to the Annual General Meeting of Orion Corporation
Feb 7th 2012 12:00 PM Stock Exchange Release

Orion Group Financial Statement Release for 2011
Feb 7th 2012 9:35 AM Stock Exchange Release

Orion continues development of inhalable budesonide-formoterol combined formulation
Jan 30th 2012 12:35 PM Stock Exchange Release

Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2012 AGM of Orion Corporation
Jan 20th 2012 9:30 AM Stock Exchange Release

Orion Corporation: Annual Summary of Stock Exchange Releases published in 2011
Jan 20th 2012 8:00 AM Stock Exchange Release

Orion invites analysts and media to Financial Statement Release conference on Tuesday 7 February 2012

2012

U.S. District Court gives decision on Precedex® patent litigation

Orion sues Mylan in the U.S. to enforce its U.S. patents covering the proprietary drug Stalevo®

Orion Group Interim Report January-March 2012

Orion invites analysts and media to Q1 news conference on Tuesday 24 April 2012

Orion Corporation: 300,000 Orion A-shares converted into B-shares

Orion comments on ANDA filed by Mylan Pharmaceuticals Inc. for a generic version of Orion's proprietary drug Stalevo® in the United States

Orion Oyj : Orion Corporation: Organising meeting of the Board of Directors

Orion Oyj : Decisions by the AGM on 20 March 2012

Orion Corporation: Transfer of 87,763 own B-shares on 12 March 2012

Orion Group Annual Report 2011 published

Notice to the Annual General Meeting of Orion Corporation

Orion Group Financial Statement Release for 2011

Orion continues development of inhalable budesonide-formoterol combined formulation

Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2012 AGM of Orion Corporation

Orion Corporation: Annual Summary of Stock Exchange Releases published in 2011

Orion invites analysts and media to Financial Statement Release conference on Tuesday 7 February 2012

Archive

2012

2011

2010

2009

2008

2007

2006